Antonio Edwards
Family Medicine · Plaquemine, LANPI 1568515419
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 115 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $869 and has fallen 94.8% since, to $45 in 2023.
Across 115 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$546
- Lilly USA, LLC$489
- AbbVie$399
- Indivior Inc.$237
- Boehringer Ingelheim$196
- Novo Nordisk$147
- plus $596 from 13 others
Across 1 payment — averaging $150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Indivior Inc.$150
What the payments were for
- Food & beverage$2,59299%
- Education$181%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 14 | $546 |
| Lilly USA, LLC | 24 | $489 |
| AbbVie(2 entities) | 24 | $399 |
| Indivior Inc. | 12 | $237 |
| Boehringer Ingelheim | 12 | $196 |
| Novo Nordisk | 5 | $147 |
| Avanir Pharmaceuticals, Inc. | 2 | $139 |
| Smith+Nephew | 1 | $122 |
| Currax Pharmaceuticals LLC | 7 | $90 |
| Novartis | 4 | $76 |
| Ironshore Pharmaceuticals Inc. | 2 | $34 |
| GSK | 1 | $20 |
| Gilead | 1 | $20 |
| Pfizer | 1 | $17 |
| Global Blood Therapeutics, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,609 in reported general payments places this provider in the 70th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Plaquemine
- Brandon WeeksPlaquemine$13K
- Christine SmithBaton Rouge$185K
- Thomas DansbyMonroe$169K
- Michael FlemingShreveport$165K
- Robert St AmantGonzales$156K
- William HathawaySpringhill$105K
- Cesar GonzalesWest Monroe$94K
- Phillip ConnerSulphur$71K
- Richard JeansonneMandeville$49K
- Leonard TreanorHammond$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.